| Literature DB >> 29742306 |
Ashootosh Tripathi1,2, Sung Ryeol Park1,3, Andrew P Sikkema1,4,5, Hyo Je Cho6, Jianfeng Wu7, Brian Lee1, Chuanwu Xi7, Janet L Smith1,4, David H Sherman1,2,8,9.
Abstract
Cahuitamycins are biofilm inhibitors assembled by a convergent nonribosomal peptide synthetase pathway. Previous genetic analysis indicated that a discrete enzyme, CahJ, serves as a gatekeeper for cahuitamycin structural diversification. Here, the CahJ protein was probed structurally and functionally to guide the formation of new analogues by mutasynthetic studies. This analysis enabled the in vivo production of a new cahuitamycin congener through targeted precursor incorporation.Entities:
Keywords: adenylation domains; biosynthesis; kinetics; natural products; protein structures
Mesh:
Substances:
Year: 2018 PMID: 29742306 PMCID: PMC6105470 DOI: 10.1002/cbic.201800233
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164